Pharma-Bio Serv (PBSV) EBITDA Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Pharma-Bio Serv (PBSV) EBITDA Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 272.00 |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 140.00 |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 367.00 |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 396.00 |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 113.00 |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 13.00 |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 338.00 |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | -170.00 |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 519.00 |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -298.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -298.00 |
| Jan 31, 2026 | -1,187.00 |
| Oct 31, 2025 | -984.00 |
| Jul 31, 2025 | -2,373.00 |
| Apr 30, 2025 | -972.00 |
| Jan 31, 2025 | -1,082.00 |
| Oct 31, 2024 | 7,912.00 |
| Jul 31, 2024 | -2,302.00 |
| Apr 30, 2024 | -1,843.00 |
| Jan 31, 2024 | -2,552.00 |
| Oct 31, 2023 | -446.00 |
| Jul 31, 2023 | -295.00 |
| Apr 30, 2023 | -443.00 |
| Jan 31, 2023 | -388.00 |
| Oct 31, 2022 | -520.00 |
| Jul 31, 2022 | 48.00 |
| Apr 30, 2022 | -361.00 |
| Jan 31, 2022 | -323.00 |
| Oct 31, 2021 | -9,449.00 |
| Jul 31, 2021 | -836.00 |